FANCB and cardiovascular disorder: In this regard, FA2G2S1 (N-glycan in our GP22) was negatively associated with both atherosclerotic cardiovascular risk (44), and FA2[3]G1 (our GP9) was negatively associated with both atherosclerotic cardiovascular risk (44) and cardiovascular disease incidence in women (45).